Elidel-Study: Elidel in Patients With Atopic Dermatitis

Phase 4

Completed

• Conditions: Atopic Dermatitis

• Registration Number: NCT00180141
• Lead Sponsor: Technische Universität Dresden

Brief Summary

Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-16
• Primary Completion: 2007-03
• Study Completion: 2007-06
• Status Verified: 2008-05
• Last Update Submitted: 2008-05-06
• Last Update Posted: 2008-05-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Age > 18 years
• Atopic dermatitis on both lower arms at least 1% body surface area.
• Atopic Dermatitis Severity Index (ADSI)-Score >= 6
• Investigator Global Assessment (IGA)-Score >= 2

Exclusion Criteria

• Systemic therapy with immunosuppressive drugs within the past 24 weeks
• Phototherapy against atopic dermatitis.
• Antibiotic therapy against atopic dermatitis.
• Allergy against Elidel.
• Pregnancy
• Nursing
• Skin cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Technical University Dresden; 🇩🇪 Dresden, Sachsen, Germany